Renal Myfibroblast: Origins and Activation

$331,688R01FY2013DKNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Paper 39361724 Paper 38732210 Paper 38418382 Paper 36150768 Paper 35341792 Paper 35142744 Paper 34976212 Paper 32339988 Paper 31743113 Paper 31647783 Paper 31461626 Paper 30878215 Paper 30770219 Paper 30770217 Paper 30710617 Paper 30409456 Paper 30093080 Paper 29895976 Paper 29389516 Paper 29343518 Paper 28336721 Paper 28270411 Paper 27921041 Paper 27804998 Paper 27624489 Paper 27612995 Paper 27333788 Paper 26808707 Paper 26759038 Paper 26714578 Paper 26692289 Paper 26475416 Paper 26453613 Paper 26312156 Paper 26055352 Paper 25804282 Paper 25644107 Paper 25071087 Paper 25012166 Paper 24744439 Paper 24371299 Paper 24265790 Paper 23825074 Paper 23715119 Paper 23698793 Paper 23559584 Paper 22622501 Paper 22492945 Paper 22302193 Paper 22278018 Paper 22095947 Paper 22009250 Paper 21832980 Paper 21816937 Paper 21390327 Paper 21189258 Paper 21030600 Paper 20663893 Paper 20639453 Paper 20519507 Paper 20505657 Paper 20375988 Paper 20019167 Paper 19759524 Paper 19628668 Paper 19541809 Paper 19297557 Paper 18525004 Paper 18508579 Paper 18502824 Paper 18353873 Paper 18202193 Paper 18199803 Paper 18037995 Paper 17656471 Paper 17625116 Paper 17207995 Paper 17202424 Paper 17121787 Paper 17082242 Paper 16959829 Paper 16837631 Paper 16651617 Paper 16408108 Paper 16332928 Paper 16303771 Paper 16291834 Paper 16192631 Paper 16164627 Paper 16049329 Paper 15537870 Paper 15466268 Paper 15339794 Paper 15180923 Paper 15153551 Paper 14694152 Paper 14638915 Paper 12925691 Paper 12875981 Paper 12746445

Abstract

DESCRIPTION (provided by applicant): Tubulointerstitial fibrosis, a common endpoint outcome of a wide range of chronic kidney diseases (CKD), is preceded by activation of the a-smooth muscle actin-positive myofibroblasts, the principal effector cells that are responsible for the over-production of extracellular matrix components. This is the A1 revision of a R01 competitive renewal application, which proposes to continue our long- term efforts to elucidate the origins, activation and regulation of myofibroblasts in renal fibrogenesis. Studies in previous project period of this application indicate that dysregulated activation of key developmental signaling such as sonic hedgehog (Shh) and Wnt/beta-catenin plays a critical role in mediating fibroblast activation and renal fibrosis. In this renewal application, studies are designed to testa central hypothesis that Shh and Wnts mediate a two-way cross-talk between tubular epithelium and interstitial fibroblasts, and such 'epithelial-mesenchymal communication (EMC)' plays an essential role in promoting fibroblast activation and matrix production. The entire application consists of three specific aims. Aim 1 is to investigate the role of tubule-derived Shh in promoting fibroblast proliferation and activation. Aim 2 is to investigate the role of fibroblast-derived Wnts in mediating the fibrogenic responses of tubular epithelium. Aim 3 is to investigate the therapeutic effects of blocking Shh or/and Wnt signaling with small molecule inhibitors or endogenous antagonist on renal fibrosis. These studies promise to offer important insights into understanding how tubular injury in diseased kidneys drives fibroblast proliferation and activation, leading to excessive matrix production and scar formation. Undoubtedly, the data generated from this application will have wide implications in comprehending the pathogenesis of renal fibrosis after injury, as well as in designing future therapeutic regimens for treatment.

View original record on NIH RePORTER →